Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
R S Weinstein, … , A M Parfitt, S C Manolagas
R S Weinstein, … , A M Parfitt, S C Manolagas
Published July 15, 1998
Citation Information: J Clin Invest. 1998;102(2):274-282. https://doi.org/10.1172/JCI2799.
View: Text | PDF
Research Article Article has an altmetric score of 17

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

  • Text
  • PDF
Abstract

Glucocorticoid-induced bone disease is characterized by decreased bone formation and in situ death of isolated segments of bone (osteonecrosis) suggesting that glucocorticoid excess, the third most common cause of osteoporosis, may affect the birth or death rate of bone cells, thus reducing their numbers. To test this hypothesis, we administered prednisolone to 7-mo-old mice for 27 d and found decreased bone density, serum osteocalcin, and cancellous bone area along with trabecular narrowing. These changes were accompanied by diminished bone formation and turnover, as determined by histomorphometric analysis of tetracycline-labeled vertebrae, and impaired osteoblastogenesis and osteoclastogenesis, as determined by ex vivo bone marrow cell cultures. In addition, the mice exhibited a threefold increase in osteoblast apoptosis in vertebrae and showed apoptosis in 28% of the osteocytes in metaphyseal cortical bone. As in mice, an increase in osteoblast and osteocyte apoptosis was documented in patients with glucocorticoid-induced osteoporosis. Decreased production of osteoclasts explains the reduction in bone turnover, whereas decreased production and apoptosis of osteoblasts would account for the decline in bone formation and trabecular width. Furthermore, accumulation of apoptotic osteocytes may contribute to osteonecrosis. These findings provide evidence that glucocorticoid-induced bone disease arises from changes in the numbers of bone cells.

Authors

R S Weinstein, R L Jilka, A M Parfitt, S C Manolagas

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 1992 1991 1988 1974 1968 1966 Total
Citations: 11 22 28 34 52 51 45 53 57 62 49 55 53 68 69 56 63 46 55 52 52 33 50 42 40 37 11 1 1 1 1 1 1 1 1 3 1257
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (46)

Title and authors Publication Year
Control of bone mass and remodeling by PTH receptor signaling in osteocytes
CA O'Brien, LI Plotkin, C Galli, JJ Goellner, AR Gortazar, MR Allen, AG Robling, M Bouxsein, E Schipani, CH Turner, RL Jilka, RS Weinstein, SC Manolagas, T Bellido
PloS one 2008
Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis
TJ Martin, NA Sims, KW Ng
Osteoporosis International 2008
Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation
MJ Christopher, DC Link
Journal of Bone and Mineral Research 2008
Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation
M Dominici, R Marino, V Rasini, C Spano, P Paolucci, P Conte, TJ Hofmann, EM Horwitz
Blood 2008
Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization
W Yao, Z Cheng, A Pham, C Busse, EA Zimmermann, RO Ritchie, NE Lane
Arthritis & Rheumatism 2008
Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study
Y Kuroki, H Kaji, S Kawano, F Kanda, Y Takai, M Kajikawa, T Sugimoto
Journal of Bone and Mineral Metabolism 2008
Glucocorticoid Excess in Mice Results in Early Activation of Osteoclastogenesis and Adipogenesis and Prolonged Suppression of Osteogenesis
W Yao, Z Cheng, C Busse, A Pham, MC Nakamura, NE Lane
Arthritis & Rheumatism 2008
Inhibin and the regulation of bone mass
D Gaddy
Current Osteoporosis Reports 2008
Glucocorticoids and the risk of osteoporosis
L Caplan, KG Saag
Expert Opinion on Drug Safety 2008
Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
FS Wang, JY Ko, DW Yeh, HC Ke, HL Wu
Endocrinology 2008
Risk Factors, Prevention, and Treatment of Corticosteroid-Induced Osteoporosis in Adults
KM Ruf, NK Johnson, T Clifford, KM Smith
Orthopedics 2008
The pituitary–adrenal axis and body composition
E Fernandez-Rodriguez, PM Stewart, MS Cooper
Pituitary 2008
IL-6 receptor expression and IL-6 effects change during osteoblast differentiation
Y Li, CM Bäckesjö, LA Haldosén, U Lindgren
Cytokine 2008
Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo
LI Plotkin, V Lezcano, J Thostenson, RS Weinstein, SC Manolagas, T Bellido
Journal of Bone and Mineral Research 2008
Osteocytes, mechanosensing and Wnt signaling
LF Bonewald, ML Johnson
Bone 2008
Regulation of bim in glucocorticoid-mediated osteoblast apoptosis
B Espina, M Liang, RG Russell, PA Hulley
Journal of Cellular Physiology 2008
Pre-receptorial regulation of steroid hormones in bone cells: Insights on glucocorticoid-induced osteoporosis
S Pierotti, L Gandini, A Lenzi, AM Isidori
The Journal of Steroid Biochemistry and Molecular Biology 2008
Influence of host periosteum and recipient bed perforation on the healing of onlay mandibular bone graft: an experimental pilot study in the sheep
WL Adeyemo, T Reuther, W Bloch, Y Korkmaz, JH Fischer, JE Zöller, AC Kuebler
Oral and Maxillofacial Surgery 2008
Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2
V Alonso, AR de Gortázar, JA Ardura, I Andrade-Zapata, MV Alvarez-Arroyo, P Esbrit
Journal of Cellular Physiology 2008
Osteocytes in the pathogenesis of osteoporosis
K Ikeda
Geriatrics & Gerontology International 2008
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
BL Clarke
Yearbook of Endocrinology 2008
Risk factors for avascular necrosis among Filipino patients with systemic lupus erythematosus
L HAMIJOYO, LJ LLAMADO, SV NAVARRA
International Journal of Rheumatic Diseases 2008
Stathmin-like 2, a developmentally-associated neuronal marker, is expressed and modulated during osteogenesis of human mesenchymal stem cells
C Chiellini, G Grenningloh, O Cochet, M Scheideler, Z Trajanoski, G Ailhaud, C Dani, EZ Amri
Biochemical and Biophysical Research Communications 2008
Regenerative effects of transplanting autologous mesenchymal stem cells on corticosteroid-induced osteonecrosis in rabbits
H Matsuya, T Kushida, T Asada, M Umeda, T Wada, H Iida
Modern Rheumatology 2008
The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells
D Hong, HX Chen, RS Ge, JC Li
The Journal of Steroid Biochemistry and Molecular Biology 2008
Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats
Y Fujita, T Konoo, K Maki
Orthodontics & Craniofacial Research 2008
Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry
T Ogoshi, H Hagino, S Fukata, S Tanishima, T Okano, R Teshima
Modern Rheumatology 2008
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells
A Kallio, T Guo, E Lamminen, J Seppänen, L Kangas, HK Väänänen, P Härkönen
Molecular and Cellular Endocrinology 2008
11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Periprosthetic Osteolysis
RZ Tashjian, C Lin, B Aswad, RM Terek
Orthopedics 2008
Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
S Dolgos, A Hartmann, S Bønsnes, T Ueland, GA Isaksen, K Godang, P Pfeffer, J Bollerslev
Clinical Transplantation 2008
Characterization of a new experimental model of osteoporosis in rabbits
S Castañeda, E Calvo, R Largo, R González-González, C la Piedra, M Díaz-Curiel, G Herrero-Beaumont
Journal of Bone and Mineral Metabolism 2008
The Effect of Low-Dose Cholecalciferol and Calcium Treatment on Posttransplant Bone Loss in Renal Transplant Patients: A Prospective Study
G Sahin, NS Yasar, B Sirmagul, C Bal, AU Yalcin
Renal Failure 2008
Pharmacological agents and impairment of fracture healing: What is the evidence?
I Pountos, T Georgouli, TJ Blokhuis, HC Pape, PV Giannoudis
Injury 2008
Complicaciones osteoarticulares de los trasplantes de ��rganos
G Ayoub, T Bardin
EMC - Aparato Locomotor 2008
Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides de la Sociedad Española de Medicina Interna
MS Henríquez, MD Curiel, AD Pérez, CG Alonso, JG Macías, JF Minguella, JF Rubio, LM Saidler, XN Solán, DH Hernández
Revista Clínica Española 2008
Apoptosis in Bone for Tissue Engineering
GM Bran, J Stern-Straeter, K Hörmann, F Riedel, UR Goessler
Archives of Medical Research 2008
Metabolic traits affecting growth rates of pre-pubertal calves and their relationship with subsequent survival
A Swali, Z Cheng, N Bourne, DC Wathes
Domestic Animal Endocrinology 2008
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Patogenia de la osteoporosis esteroidea
BE Riera, J González-Macías
Revista Española de Enfermedades Metabólicas Óseas 2008
Bisphosphonate-Associated Osteomyelitis of the Jaw: Guidelines for Practicing Clinicians
SJ Wimalawansa
Endocrine Practice 2008
Bone involvement in exogenous hypercortisolism
L Sinigaglia, D Mazzocchi, M Varenna
Journal of Endocrinological Investigation 2008
Dexamethasone differentially regulates renal and duodenal calcium-processing genes in calbindin-D9k and -D28k knockout mice: Regulation of calcium-processing genes by dexamethasone
MH Kim, GS Lee, EM Jung, KC Choi, GT Oh, EB Jeung
Experimental Physiology 2008
BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization
CA Luppen, CA Luppen, RL Chandler, T Noh, DP Mortlock, B Frenkel
Growth Factors 2008
Estudo da densidade mineral óssea em pacientes com lúpus eritematoso sistêmico antes e após uso de glicocorticóides
F Amarante, SS de Souza, V Borges, CJ Feldman
Radiologia Brasileira 2008
Characterization of a new experimental model of osteoporosis in rabbits.
Castañeda S, Calvo E, Largo R, González-González R, de la Piedra C, Díaz-Curiel M, Herrero-Beaumont G
Journal of Bone and Mineral Metabolism 2008
Skeletal involvement in adult patients with endogenous hypercortisolism.
Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A
Journal of Endocrinological Investigation 2008

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 15 patents
Referenced in 2 clinical guideline sources
377 readers on Mendeley
1 readers on CiteULike
See more details